Jansen T L, Janssen M, de Jong A J
Department of Rheumatology, Rijnstate Hospital, Arnhem, The Netherlands.
J Rheumatol. 1998 Jun;25(6):1126-30.
Group A beta-hemolytic streptococci (GAS) are known to be capable of evoking sterile arthritis. Reactive arthritis (ReA) has been reported sporadically following primary infection with group C and group G beta-hemolytic streptococci (GCS, GGS). We prospectively studied 4 cases of ReA secondary to throat infection with GCS and GGS.
Four patients with arthritis secondary to throat infection were seen. Three patients were Dutch, one was Indonesian; female/male ratio was 1/3; mean age was 30 years (range 18-46). Diagnostic evaluation included culture of throat swab and serological screening.
All patients presented with a nonmigratory asymmetrical arthritis: monoarthritis in one patient, oligoarthritis in 3. Culture of throat swab was positive in all. Antistreptolysin-O (ASO) titer rose significantly in 2 patients, and anti-DNase-B rose in 2 patients. ASO was maximal (mean 1000 U/ml; range 890-1110) and anti-DNase-B was 395 U/ml (range 290-500). Treatment consisted of feneticillin for 5 days; nonsteroidal antiinflammatory drugs were prescribed on demand. All patients recovered fully in 3 to 12 weeks.
These cases provide evidence of a benign non-group A streptococcal ReA, i.e., secondary to GCS or GGS. The presence of the organism in the throat along with the elevation of antibody to streptococcal products is important for the diagnosis of GCS/GGS associated ReA. A positive throat culture is needed for differentiation from GAS associated poststreptococcal ReA, because prophylactic measures are effective only in GAS associated sequelae, but not in GCS/GGS associated ReA.
已知A组β溶血性链球菌(GAS)能够引发无菌性关节炎。C组和G组β溶血性链球菌(GCS、GGS)原发性感染后偶有反应性关节炎(ReA)的报道。我们前瞻性地研究了4例继发于GCS和GGS咽喉感染的ReA病例。
观察了4例继发于咽喉感染的关节炎患者。3例为荷兰人,1例为印度尼西亚人;男女比例为1/3;平均年龄为30岁(范围18 - 46岁)。诊断评估包括咽喉拭子培养和血清学筛查。
所有患者均表现为非游走性不对称关节炎:1例为单关节炎,3例为寡关节炎。所有患者咽喉拭子培养均为阳性。2例患者抗链球菌溶血素O(ASO)滴度显著升高,2例患者抗脱氧核糖核酸酶B升高。ASO最高值(平均1000 U/ml;范围890 - 1110),抗脱氧核糖核酸酶B为395 U/ml(范围290 - 500)。治疗包括使用非奈西林5天;按需开具非甾体抗炎药。所有患者在3至12周内完全康复。
这些病例提供了一种良性非A组链球菌ReA的证据,即继发于GCS或GGS。咽喉部存在该病原体以及抗链球菌产物抗体升高对于诊断GCS/GGS相关ReA很重要。需要咽喉培养阳性以与GAS相关的链球菌感染后ReA相鉴别,因为预防措施仅对GAS相关后遗症有效,而对GCS/GGS相关ReA无效。